SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ | Definitive Proxy Statement |
☒ | Definitive Additional Materials |
☐ | Soliciting Material Under Rule 14(a)(12) |
cbdMD, Inc.
(Name of Registrant as Specified in Its Charter)
Not Applicable
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
☒ | No fee required. |
☐ | Fee paid previously with preliminary materials |
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
cbdMD, Inc. Files Investor Presentation
cbdMD, Inc. (the “Company”) filed an investor presentation with the U.S. Securities and Exchange Commission (“SEC”) on February 29, 2024 including information in connection with its upcoming Annual Meeting of Shareholders scheduled to be held on March 29, 2024. Shareholders of record as of January 30 2024 will be entitled to vote at the meeting. The presentation is provided below.
